HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hepatic glucose cycling does not contribute to the development of hyperglycemia in Zucker diabetic fatty rats.

Abstract
Hepatic glucose cycling, whereby glucose is taken up by the liver, partially metabolized, then recycled to glucose, makes a substantial contribution to the development of hyperglycemia in IDDM. This stimulation of glucose cycling appears to be associated with elevated rates of fatty acid oxidation. Whether hepatic glucose cycling also contributes to the development of hyperglycemia in NIDDM is unclear. Using a model of NIDDM, the Zucker diabetic fatty (ZDF) rat, we determined whether glucose cycling was enhanced. Hepatocytes from ZDF rats exhibited higher rates of glucose phosphorylation and glycolysis, but there was no increase in the rate of cycling between glucose and glucose-6-phosphate or between glycolytically derived pyruvate and glucose. Despite the increased rates of glycolysis, the production of CO2 in liver cells from ZDF rats was no different from rates measured in cells from control animals. Instead, there was a large increase in the accumulation of lactate and pyruvate in the ZDF liver cells. The addition of 2-bromopalmitate, an inhibitor of fatty acid oxidation that inhibited glucose cycling in hepatocytes from IDDM rats, had no effect on glucose cycling in cells from ZDF rats. We therefore conclude that, unlike in IDDM, hepatic glucose cycling does not contribute to the development of hyperglycemia in the NIDDM Zucker rat.
AuthorsD C Henly, M C Chauvet, J W Phillips
JournalDiabetes (Diabetes) Vol. 48 Issue 2 Pg. 342-6 (Feb 1999) ISSN: 0012-1797 [Print] United States
PMID10334311 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Fatty Acids
  • Palmitates
  • 2-bromopalmitate
  • Glucose
Topics
  • Animals
  • Diabetes Mellitus (metabolism)
  • Diabetes Mellitus, Type 2 (metabolism, pathology, physiopathology)
  • Fatty Acids (metabolism)
  • Glucose (metabolism)
  • Hyperglycemia (etiology)
  • Liver (metabolism, pathology)
  • Obesity
  • Oxidation-Reduction (drug effects)
  • Palmitates (pharmacology)
  • Rats
  • Rats, Zucker (physiology)
  • Reference Values

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: